Related references
Note: Only part of the references are listed.Progressive Tumor Formation in Mice with Conditional Deletion of TGF-β Signaling in Head and Neck Epithelia Is Associated with Activation of the PI3K/Akt Pathway
Yansong Bian et al.
CANCER RESEARCH (2009)
Akt Activation Synergizes with Trp53 Loss in Oral Epithelium to Produce a Novel Mouse Model for Head and Neck Squamous Cell Carcinoma
Marta Moral et al.
CANCER RESEARCH (2009)
YAP At the crossroad between transformation and tumor suppression
Efrem Bertini et al.
CELL CYCLE (2009)
Negative regulation of YAP by LATS1 underscores evolutionary conservation of the Drosophila Hippo pathway
Jianmin Zhang et al.
CANCER RESEARCH (2008)
Yes-associated protein (YAP) functions as a tumor suppressor in breast
M. Yuan et al.
CELL DEATH AND DIFFERENTIATION (2008)
Inhibition of Mammalian Target of Rapamycin by Rapamycin Causes the Regression of Carcinogen-induced Skin Tumor Lesions
Panomwat Amornphimoltham et al.
CLINICAL CANCER RESEARCH (2008)
The jury is in: p73 is a tumor suppressor after all
Jennifer M. Rosenbluth et al.
GENES & DEVELOPMENT (2008)
Expression of Yes-associated protein in common solid tumors
Angela A. Steinhardt et al.
HUMAN PATHOLOGY (2008)
A signal network involving coactivated NF-κB and STAT3 and altered p53 modulates BAX/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas
Tin Lap Lee et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Mst2 and lats kinases regulate apoptotic function of Yes kinase-associated protein (YAP)
Tsutomu Oka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
YAP and p73: A Complex Affair
Julian Downward et al.
MOLECULAR CELL (2008)
Yap1 phosphorylation by c-AbI is a critical step in selective activation of proapoptotic genes in response to DNA damage
Dan Levy et al.
MOLECULAR CELL (2008)
Yes-Associated Protein (YAP) is a critical mediator of c-Jun-dependent apoptosis
S. A. Danovi et al.
CELL DEATH AND DIFFERENTIATION (2008)
Deficient TP53 expression, function, and cisplatin sensitivity are restored by quinacrine in head and neck cancer
Jay Friedman et al.
CLINICAL CANCER RESEARCH (2007)
Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control
Bin Zhao et al.
GENES & DEVELOPMENT (2007)
A novel nuclear factor-κB gene signature is differentially expressed in head and neck squamous cell carcinomas in association with TP53 status
Tin Lap Lee et al.
CLINICAL CANCER RESEARCH (2007)
RASSRA elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the P73 tumor suppressor protein
David Matallanas et al.
MOLECULAR CELL (2007)
Genome-wide identification of novel expression signatures reveal distinct patterns and prevalence of binding motifs of p53, NF-kappaB and other signal transcription factors in head and neck squamous cell carcinoma
Bin Yan et al.
GENOME BIOLOGY (2007)
Dissecting the Akt/Mammalian target of rapamycin signaling network: Emerging results from the head and neck cancer tissue array initiative
Alfredo A. Molinolo et al.
CLINICAL CANCER RESEARCH (2007)
The Yes-associated protein 1 stabilizes p73 by preventing Itch-mediated ubiquitination of p73
D. Levy et al.
CELL DEATH AND DIFFERENTIATION (2007)
Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon
Michael Overholtzer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Loss of p63 leads to increased cell migration and up-regulation of genes involved in invasion and metastasis
Christopher E. Barbieri et al.
CANCER RESEARCH (2006)
Protein kinase casein kinase 2 mediates inhibitor-κB kinase and aberrant nuclear factor-κB activation by serum factor(s) in head and neck squamous carcinoma cells
Mng Yu et al.
CANCER RESEARCH (2006)
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach
Lars Zender et al.
CELL (2006)
p63 and p73 - Life and death in squamous cell carcinoma
James W. Rocco et al.
CELL CYCLE (2006)
Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas
TL Lee et al.
MOLECULAR CANCER THERAPEUTICS (2006)
p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis
JW Rocco et al.
CANCER CELL (2006)
Akt activation correlates with adverse outcome in tongue cancer
E Massarelli et al.
CANCER (2005)
Identification of N10-substituted phenoxazines as potent and specific inhibitors of Akt signaling
KN Thimmaiah et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Hepatocyte growth factor/scatter factor differentially regulates expression of proangiogenic factors through Egr-1 in head and neck squamous cell carcinoma
B Worden et al.
CANCER RESEARCH (2005)
Rare amplicons implicate frequent deregulation of cell fate specification pathways in oral squamous cell carcinoma
AM Snijders et al.
ONCOGENE (2005)
The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA damage
S Strano et al.
MOLECULAR CELL (2005)
Heterogeneous nuclear ribonuclear protein U associates with YAP and regulates its co-activation of Bax transcription
M Howell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Persistent activation of the Akt pathway in head and neck squamous cell carcinoma: a potential target for UCN-01
P Amornphimoltham et al.
CLINICAL CANCER RESEARCH (2004)
WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus
A Komuro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The ΔNp63α phosphoprotein binds the p21 and 14-3-3σ promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations
MD Westfall et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis
S Basu et al.
MOLECULAR CELL (2003)
Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-κB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines
CC Bancroft et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Medical progress - Head and neck cancer
A Forastiere et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Physical interaction with Yes-associated protein enhances p73 transcriptional activity
S Strano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
p53AlP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53
K Oda et al.
CELL (2000)
Share Paper
